Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

4D Molecular Therapeutics (FDMT) Interest & Investment Income (2020 - 2025)

Historic Interest & Investment Income for 4D Molecular Therapeutics (FDMT) over the last 6 years, with Q3 2025 value amounting to $4.3 million.

  • 4D Molecular Therapeutics' Interest & Investment Income fell 4060.36% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.2 million, marking a year-over-year decrease of 1492.21%. This contributed to the annual value of $27.0 million for FY2024, which is 12152.16% up from last year.
  • As of Q3 2025, 4D Molecular Therapeutics' Interest & Investment Income stood at $4.3 million, which was down 4060.36% from $4.9 million recorded in Q2 2025.
  • 4D Molecular Therapeutics' 5-year Interest & Investment Income high stood at $7.5 million for Q2 2024, and its period low was -$312000.0 during Q4 2021.
  • Its 5-year average for Interest & Investment Income is $3.0 million, with a median of $2.5 million in 2023.
  • Data for 4D Molecular Therapeutics' Interest & Investment Income shows a peak YoY increase of 1077500.0% (in 2021) and a maximum YoY decrease of 790000.0% (in 2021) over the last 5 years.
  • Over the past 5 years, 4D Molecular Therapeutics' Interest & Investment Income (Quarter) stood at -$312000.0 in 2021, then skyrocketed by 528.85% to $1.3 million in 2022, then surged by 227.35% to $4.4 million in 2023, then surged by 47.65% to $6.5 million in 2024, then tumbled by 33.04% to $4.3 million in 2025.
  • Its Interest & Investment Income was $4.3 million in Q3 2025, compared to $4.9 million in Q2 2025 and $5.6 million in Q1 2025.